RIO DE JANEIRO, Brazil / ConSynSer / – Brazil has recorded its first death from mpox in 2026, though public health authorities do not consider the rise in infections to have reached the level of an outbreak. The country has logged 1,009 confirmed cases of the virus this year, according to a report released on Friday, November 13, by Fiocruz, a public research institute affiliated with the Ministry of Health.

The death occurred in Rio de Janeiro, where the number of confirmed cases between September and November was double the total recorded during the rest of the year. The patient was a man aged between 40 and 49 with pre-existing health conditions who was treated at Fiocruz, according to AFP. The national figures in the Fiocruz report are current as of November 12. Brazilian media reported that the death occurred in late October.
Rio de Janeiro sees sharp rise
Rio de Janeiro state had recorded 382 confirmed cases through November 13, with about 71% of them in the city of Rio de Janeiro, according to state data. Brazil’s Ministry of Health has purchased 25,000 doses of mpox vaccine. Officials said case numbers remain well below the peak seen in 2022, which is why the increase has not been classified as an outbreak. Fiocruz is headquartered in Rio de Janeiro and is one of Latin America’s leading health research institutions.
The World Health Organization declared mpox a global Public Health Emergency of International Concern in 2022 and again in 2024, as the virus spread rapidly in several countries. The first emergency ended in May 2023 and the second in September 2025. During the 2024 wave, mpox concerns prompted action in Italy, South Korea and France as countries stepped up surveillance. The 2024 emergency was driven by the spread of a new strain, clade Ib, from the Democratic Republic of the Congo.
Symptoms and transmission
Mpox is a viral illness caused by the monkeypox virus, a species of the genus Orthopoxvirus. Common symptoms are a skin rash or mucosal lesions that can last two to four weeks. They are often accompanied by fever, headache, muscle aches, back pain, low energy and swollen lymph nodes. Most people recover, but the illness can be severe for those with weakened immune systems. The WHO renamed the disease from monkeypox to mpox in 2022.
The virus can spread through close contact with someone who has mpox, through contaminated materials or through infected animals. Health authorities advise people with symptoms to seek medical care and avoid close contact with others. Vaccination is recommended for groups at higher risk of exposure. Brazil’s vaccine purchase is aimed at protecting those most likely to be infected. Brazil was among the countries most affected during the 2022 global outbreak.
Public health experts say clear information and trust in science are key to controlling outbreaks of infectious diseases. The WHO recently launched a new global movement to strengthen trust in science, backed by more than 240 organizations. Fiocruz said it will continue monitoring mpox cases across Brazil and publishing regular updates on infections and deaths. The institute was founded in 1900. Brazil’s health system has been tracking mpox since the first cases were detected in 2022.
